Amphastar Pharmaceuticals amends bylaws to update director nomination procedures and adopt forum selection clause

Amphastar Pharmaceuticals, Inc.

Board approved Amended and Restated Bylaws on Feb 23, 2023.
New requirement for stockholders to deliver evidence of compliance with Rule 14a-19 no later than five business days before meeting.
Adopted forum selection provision for claims under the Securities Act of 1933.
Updated provisions on directors, committees, officers, and conformed to Delaware General Corporation Law.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Amphastar Pharmaceuticals, Inc.: Approved Amended and Restated Bylaws revising director nomination and stockholder proposal procedures, stockholder meeting procedures, director/committee/officer provisions, and adding a forum selection clause (effective 2023-02-23).

Change: bylaw amendment
Effective: 2023-02-23

Exact text from the filing

On February 23, 2023, the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”) approved the Company’s Amended and Restated Bylaws (the “Amended and Restated Bylaws”).

View on SEC.gov

Browse all governance changes →

Amphastar Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001297184-23-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.